These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 15817812

  • 21. The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids.
    Popowski K, Eloranta JJ, Saborowski M, Fried M, Meier PJ, Kullak-Ublick GA.
    Mol Pharmacol; 2005 May; 67(5):1629-38. PubMed ID: 15692145
    [Abstract] [Full Text] [Related]

  • 22. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice.
    Gregoire FM, Zhang Q, Smith SJ, Tong C, Ross D, Lopez H, West DB.
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E703-13. PubMed ID: 11832376
    [Abstract] [Full Text] [Related]

  • 23. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
    Kast HR, Nguyen CM, Sinal CJ, Jones SA, Laffitte BA, Reue K, Gonzalez FJ, Willson TM, Edwards PA.
    Mol Endocrinol; 2001 Oct; 15(10):1720-8. PubMed ID: 11579204
    [Abstract] [Full Text] [Related]

  • 24. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.
    Zhang S, Liu Q, Wang J, Harnish DC.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):476-9. PubMed ID: 19118524
    [Abstract] [Full Text] [Related]

  • 25. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO, Plass JR, Heegsma J, Geuken M, van Rijsbergen D, Baller JF, Kuipers F, Moshage H, Jansen PL, Faber KN.
    Hepatology; 2009 Jan 06; 49(1):151-9. PubMed ID: 19111018
    [Abstract] [Full Text] [Related]

  • 26. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J, Monte MJ, Dominguez M, Muntané J, Marin JJ.
    Biochem Pharmacol; 2013 Oct 01; 86(7):926-39. PubMed ID: 23928191
    [Abstract] [Full Text] [Related]

  • 27. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X, Burgermeister E, Geisler F, Einwächter H, Fan L, Hiber M, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, Ebert MP.
    Hepatology; 2009 Mar 01; 49(3):979-88. PubMed ID: 19072826
    [Abstract] [Full Text] [Related]

  • 28. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.
    Chen W, Owsley E, Yang Y, Stroup D, Chiang JY.
    J Lipid Res; 2001 Sep 01; 42(9):1402-12. PubMed ID: 11518759
    [Abstract] [Full Text] [Related]

  • 29. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.
    Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K, Hara S, Kikugawa K, Hayakawa M.
    FEBS J; 2009 Mar 01; 276(5):1319-32. PubMed ID: 19187229
    [Abstract] [Full Text] [Related]

  • 30. Regulation of carbohydrate metabolism by the farnesoid X receptor.
    Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, Michael LF, Burris TP.
    Endocrinology; 2005 Mar 01; 146(3):984-91. PubMed ID: 15564327
    [Abstract] [Full Text] [Related]

  • 31. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W.
    Cancer Res; 2007 Feb 01; 67(3):863-7. PubMed ID: 17283114
    [Abstract] [Full Text] [Related]

  • 32. A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
    Shih DM, Kast-Woelbern HR, Wong J, Xia YR, Edwards PA, Lusis AJ.
    J Lipid Res; 2006 Feb 01; 47(2):384-92. PubMed ID: 16269825
    [Abstract] [Full Text] [Related]

  • 33. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S.
    J Immunol; 2009 Nov 15; 183(10):6251-61. PubMed ID: 19864602
    [Abstract] [Full Text] [Related]

  • 34. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities.
    Henry KW, Carey B, Howard WR, Hoefner D, Noonan DJ.
    Yeast; 2001 Mar 30; 18(5):445-54. PubMed ID: 11255252
    [Abstract] [Full Text] [Related]

  • 35. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
    Song KH, Li T, Owsley E, Strom S, Chiang JY.
    Hepatology; 2009 Jan 30; 49(1):297-305. PubMed ID: 19085950
    [Abstract] [Full Text] [Related]

  • 36. Regulation of human liver delta-aminolevulinic acid synthase by bile acids.
    Peyer AK, Jung D, Beer M, Gnerre C, Keogh A, Stroka D, Zavolan M, Meyer UA.
    Hepatology; 2007 Dec 30; 46(6):1960-70. PubMed ID: 17975826
    [Abstract] [Full Text] [Related]

  • 37. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D.
    Arterioscler Thromb Vasc Biol; 2007 Dec 30; 27(12):2606-11. PubMed ID: 18029909
    [Abstract] [Full Text] [Related]

  • 38. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.
    Lian F, Xing X, Yuan G, Schäfer C, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, Ebert MP, Burgermeister E.
    Biochem J; 2011 Sep 01; 438(2):315-23. PubMed ID: 21619550
    [Abstract] [Full Text] [Related]

  • 39. Human kininogen gene is transactivated by the farnesoid X receptor.
    Zhao A, Lew JL, Huang L, Yu J, Zhang T, Hrywna Y, Thompson JR, de Pedro N, Blevins RA, Peláez F, Wright SD, Cui J.
    J Biol Chem; 2003 Aug 01; 278(31):28765-70. PubMed ID: 12761213
    [Abstract] [Full Text] [Related]

  • 40. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
    Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR.
    Am J Physiol Endocrinol Metab; 2004 Oct 01; 287(4):E731-8. PubMed ID: 15198932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.